Vacc-Syn Biotech Private Limited

Vacc-Syn Biotech Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2007PTC172190 Incorporated 09 July 2007 ROC Mumbai HQ Thane, Maharashtra, India
Dissolved Under Section 54 Private Limited Company pharma
Data last updated
Revenue · FY 2018
₹43.55 Lakh
▼ 91.00% YoY
EBITDA · FY 2018
*****
▼ 344.00% YoY
Net profit · FY 2018
*****
▼ 852.00% YoY
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹40.5 Cr
Satisfied ₹17.67 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
3
Latest available

About Vacc-Syn Biotech Private Limited

Data last updated: 23 July 2025

Vacc-Syn Biotech Private Limited was a private limited company based in Thane, Maharashtra, India, operated as a subsidiary of Synergy Diagnostics Private Limited. The company has been dissolved under section 54 as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It specialised in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 09 July 2007.

Registered with ROC Mumbai under CIN U24230MH2007PTC172190.

Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It was led by directors including Sanjay Prabhakar Bawsay and Kamal Kishore Gurnani.

Last AGM: 29 September 2018. Financial statements filed for year ended 31 March 2018. Office: 127 – 128 Laxmi Market 1St Floor Vartak Nagar, Thane, Maharashtra, India – 400606.

As per the financials filed for FY 2018, the company reported a revenue of ₹43.55 Lakh, a decline of 91% compared to the previous year.

The company had a reported workforce of approximately 3 employees prior to being dissolved. It operated as a subsidiary of Synergy Diagnostics Private Limited.

As per MCA filings, the company had open charges of ₹40.5 Cr and satisfied charges of ₹17.67 Cr on record.

The company has been dissolved and no longer exists as a legal entity under the Companies Act. Any contracts or dealings with a dissolved entity may be legally unenforceable. The last known website on record is vaccsynbiotech.com.

Company Details of Vacc-Syn Biotech Private Limited
CIN U24230MH2007PTC172190
Registration Number 172190
Incorporation Date 09 July 2007
ROC Mumbai
Listing Status Unlisted
Company Status Dissolved Under Section 54
Date of Last AGM 29 September 2018
Date of Balance Sheet 31 March 2018
Parent Company Synergy Diagnostics Private Limited
Compliance Status Active Compliant
Key People
Sanjay Prabhakar Bawsay Director Kamal Kishore Gurnani Irp/Rp/Liquidator Madhavi Sanjay Bawsay Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    vaccsynbiotech.com
  • Social Media
    **************
  • Registered Address
    127 – 128 Laxmi Market 1St Floor Vartak Nagar, Thane, Maharashtra, India – 400606
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare
Company report
Vacc-Syn Biotech Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vacc-Syn Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Vacc-Syn Biotech Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Vacc-Syn Biotech Private Limited

Vacc-Syn Biotech Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities *********

Auditor Details of Vacc-Syn Biotech Private Limited

Auditor information for Vacc-Syn Biotech Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.

Board of Directors of Vacc-Syn Biotech Private Limited

Vacc-Syn Biotech Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Sanjay Prabhakar Bawsay
Also directs: Synergy Diagnostics Private Limited
Director 09 Jul 2007 18 Years 11 Months As last reported
Kamal Kishore Gurnani Irp/Rp/Liquidator 08 Jan 2024 2 Years 6 Months As last reported
Madhavi Sanjay Bawsay
Also directs: Synergy Diagnostics Private Limited
Director 09 Jul 2007 18 Years 11 Months As last reported
View all directors

Financials of Vacc-Syn Biotech Private Limited FY 2018 filings available

Vacc-Syn Biotech Private Limited reported revenue of ₹43.55 Lakh (down 91% YoY) for FY 2018. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹43.55 Lakh ▼ -91%
Profit
***** ▼ -852%
EBITDA
***** ▼ -344%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Vacc-Syn Biotech Private Limited

As of FY 2017, Vacc-Syn Biotech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Vacc-Syn Biotech Private Limited

Open charges
₹40.5 Cr
Satisfied charges
₹17.67 Cr
Breakdown by lending institutions
Bank of India₹40.50 Cr
Latest charge details
DateLenderAmountStatus
22 Oct 2013 Bank of India ₹40.5 Cr Open
27 Aug 2010 Bank of India ₹10 Cr Satisfied
23 Jul 2009 Bank of India ₹7.67 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Vacc-Syn Biotech Private Limited

Vacc-Syn Biotech Private Limited has a workforce of 3 employees as of Apr 10, 2024.

Employee count
3
Active EPFO establishments
1
Employee growth
-75%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Vacc-Syn Biotech Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Vacc-Syn Biotech Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Vacc-Syn Biotech Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Vacc-Syn Biotech Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Vacc-Syn Biotech Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Vacc-Syn Biotech Private Limited

MSME Payment Delays by Vacc-Syn Biotech Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Vacc-Syn Biotech Private Limited

Subsidiaries & Group Companies of Vacc-Syn Biotech Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vacc-Syn Biotech Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Vacc-Syn Biotech Private Limited

MCA Filings & Documents of Vacc-Syn Biotech Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Vacc-Syn Biotech Private Limited

Directors
08 Jan 2024
Kamal Kishore Gurnani was appointed as a IRP/RP/Liquidator on 08 Jan 2024 & has been associated with this company since 2 years 6 months.
Activity
29 Sep 2018
Vacc-Syn Biotech Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Activity
31 Mar 2018
Vacc-Syn Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai.
Charges
01 Jul 2015
A charge registered on 27 Aug 2010 via Charge ID 10244807 with Bank Of India was fully satisfied on 01 Jul 2015.
Charges
01 Jul 2015
A charge registered on 23 Jul 2009 via Charge ID 10173388 with Bank Of India was fully satisfied on 01 Jul 2015.
Charges
30 Mar 2015
A charge with Bank Of India of Rs. 40.50 Cr registered on 22 Oct 2013 with Charge ID 10459448 was modified on 30 Mar 2015.

Frequently Asked Questions about Vacc-Syn Biotech Private Limited

Vacc-Syn Biotech Private Limited has been "Dissolved Under Section 54" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.

Vacc-Syn Biotech Private Limited is a dissolved under section 54 private limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 09 July 2007 and is registered under CIN U24230MH2007PTC172190. The company was dissolved under section 54 as per MCA records and no longer exists as a legal entity.

Vacc-Syn Biotech Private Limited was incorporated on 09 July 2007. Registered with ROC Mumbai.

The current directors of Vacc-Syn Biotech Private Limited are:

The CIN (Corporate Identification Number) of Vacc-Syn Biotech Private Limited is U24230MH2007PTC172190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Vacc-Syn Biotech Private Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available